|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
50984497
???header.onlineuser??? :
900
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"thongprasert s"???jsp.browse.items-by-author.description???
Showing items 21-23 of 23 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立臺灣大學 |
2015 |
Efficacy by blind independent central review (BICR): Post hoc analyses of the phase III, multicentre, randomised IPASS study of 1st-line gefitinib (G) vs carboplatin/paclitaxel (C/P) in Asian patients (pts) with EGFR mutation-positive advanced NSCLC
|
Mok, T.; Saijo, N.; Thongprasert, S.; Yang, J. C. -H.; Wu, Y. -L.; Young, H.; Haddad, V.; Jiang, H.; Fukuoka, M.; 楊志新 |
| 國立臺灣大學 |
2012 |
BIOMARKER ANALYSES AND OVERALL SURVIVAL (OS) FROM THE RANDOMIZED, PLACEBO-CONTROLLED, PHASE 3, FASTACT-2 STUDY OF INTERCALATED ERLOTINIB WITH FIRST-LINE CHEMOTHERAPY IN ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
|
Mok, T. S. K.; Lee, J. S.; Zhang, L.; Yu, C.; Thongprasert, S.; Ladrera, G. E. I.; Srimuninnimit, V.; Truman, M. I.; Klughammer, B.; Wu, Y. |
| 國立臺灣大學 |
2012 |
PIONEER: A PROSPECTIVE MOLECULAR EPIDEMIOLOGICAL STUDY OF EGFR MUTATIONS IN ASIAN PATIENTS (PATIENTS) WITH ADVANCED LUNG ADENOCARCINOMA (ADC)
|
Au, J. S. -K.; Yuankai, S.; Thongprasert, S.; Srinivasan, S.; Tsai, C. -M.; Khoa, M. T.; Heeroma, K.; Itoh, Y.; Cornelio, G.; Yang, P. -C.; 楊泮池 |
Showing items 21-23 of 23 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
